Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

ENDO 2026 Study Finds Most People Who Stop Ozempic or Tirzepatide for Type 2 Diabetes Eventually Restart Treatment

ENDO 2026 research published June 2026 via ScienceDaily found most GLP-1 users with type 2 diabetes who stop treatment eventually restart, driven by weight regain.

Medical Daily

Health company accused of using fake doctors for sales

Australians with diabetes, heart disease, obesity and menopause paid thousands and spoke with fake doctors who said their lives were at risk, a watchdog claims.

AAP

Drug that delays onset of type 1 diabetes approved in England and Wales

Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

NHS approves breakthrough drug that can delay type 1 diabetes for years

IN FULL

The Independent UK

Experts hail ‘new age of diabetes treatment’ as drug approved on NHS

Teplizumab is approved for children aged eight and over

The Independent UK

Diabetes, hypertension, cholesterol 'biggest burden' on B30 healthcare

Non-communicable diseases (NCDs) were the biggest burden on the universal healthcare system in fiscal 2025, with high blood pressure, high cholesterol and diabetes accounting for the largest number of patient visits.

Bangkok Post

French NutriNet-Santé Study: Natural Food Color Additives Linked to 38–49% Higher Type 2 Diabetes Risk and Increased Cancer Rates

French NutriNet-Santé studies: natural food colorants linked to 38–49% higher T2D risk and 14–32% higher cancer risk. Beta-carotene, curcumin, anthocyanins all implicated.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

The Sweetener Marketed to Diabetics May Be Silently Harming Their Livers. New Research from WashU Explains How.

Washington University Medicine study in Science Signaling: sorbitol converts to fructose in the liver when gut bacteria are overwhelmed, triggering fatty liver disease.

Medical Daily

Why a medical eye exam is more than a vision test

Osvaldo Lopez, M.D., from Chicago Arbor Eye Institute, explains that a medical eye exam is not simply a way to find out whether someone needs new glasses. It is a structured look at how the eye is functioning, what may be changing, and whether symptoms are being caused by something…

inkl

Going Completely Sugar-Free May Actually Be Making You Less Healthy. A New Study Shows Why Total Elimination Can Backfire.

ENDO 2026 / Dasman Diabetes Institute: sucrose-free low-fat mice diet produced worse blood sugar, insulin resistance, gut dysbiosis, and fatty liver vs. moderate-sucrose controls.

Medical Daily

Este Haim on 'mentally taxing' type 1 diabetes battle

During the conversation with Will Gluck, Este Haim opened up about how having type 1 diabetes - where the pancreas doesn’t produce enough insulin for the body - affects her life, as she said it’s “not fun”.

BANG Premier

Why CKD Patients Face a Silent Blood Sugar Risk

When people think about blood sugar problems, they usually focus on diabetes. The kidneys rarely enter the conversation. Yet these two systems are more connected than most people realize. Healthy kidneys help regulate blood sugar by removing excess insulin and producing glucose when the body needs energy. But when kidney…

MyLifeXP

The Science Behind Feeling Hungry All the Time

Have you ever finished a meal only to feel hungry again a short time later? Or perhaps you find yourself constantly thinking about food throughout the day. While occasional hunger is a normal signal from the body, persistent hunger can leave many people wondering what is going on. The feeling…

MyLifeXP

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MyLifeXP

How One Small Change Is Transforming TB Detection

What if one of India's biggest healthcare challenges could be tackled without a new medicine, expensive technology, or massive funding? What if the answer was something surprisingly simple? Across villages, towns, and cities, healthcare workers are discovering a quiet but powerful way to help people get screened for tuberculosis (TB).…

AAP

FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is intended for the continuous monitoring of blood sugar levels and glucose trends in…

Medical Daily

Intensive Lifestyle Changes Reduce Risk of Multimorbidity by 25 Percent in Adults with Prediabetes, 20-Year JAMA Study Reveals

A 20-year NIH study published in JAMA June 15, 2026 found intensive lifestyle changes cut multimorbidity risk by 25% in adults with prediabetes.

The Conversation

Our eyes age too: Here’s how to reduce the risks of four common eye conditions

As an optometrist, I see how aging affects my patients every day. Their eyes are no exception. Losing their vision, and consequently, their independence, is one of the greatest fears older people have. Those who lose their vision are severely affected by it psychologically.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Ed Gamble on extreme body transformations: ‘Your life is horrible’

WELL ENOUGH: The comedian is perhaps best known for a podcast all about the joy of food – but his own health journey has been far from simple, Ed Gamble tells Emilie Lavinia on the Well Enough podcast

Medical Daily

GLP-1 Drugs Like Ozempic Are Showing a 47 Percent Reduction in Breast Cancer Risk in a Major New Study — and Weight Loss May Not Explain It

A study presented at ASCO 2026 and published June 10, 2026 found that GLP-1 receptor agonists (semaglutide, tirzepatide) are associated with a 30–47% reduction in breast cancer risk among women with diabetes or obesity. The effect may operate through mechanisms beyond weight loss. Here is the full analysis.

International Business Times

Rethinking Insulin at Its Core: Hua Tu on How Stability Innovation Is Shaping the Next Generation of Diabetes Care

Every individual living with type 1 diabetes understands the discipline the condition demands. Even minor deviations can result in significant fluctuations in glucose levels.

The Conversation

Women report poor sleep despite a good night’s rest — while men overestimate their own sleep quality

Disturbed sleep is a common problem — and one that has many serious consequences beyond feeling tired the next day. Research has linked insomnia and poor sleep to early mortality and diseases including diabetes and cardiovascular disease.

The Economic Times

More sleep means good health? Answer is... Study says people with diabetes face risk of developing deadly liver disease with rise in nap time

More sleep means good health? Answer is no. Study says people with diabetes face risk of developing deadly liver disease with rise in nap time. Research presented at ENDO 2026 found that people with type 2 diabetes who take naps longer than 30 minutes may face a higher risk of…

Reason

"American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal"

Aaron Terr (FIRE) reports, based on accounts from various publications. Some excerpts: The incident occurred outside a conference hall where… The post "American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal" appeared first on Reason.com.

Reason

DHS Says He's a Terrorist. His Lawyers Say He's Being Punished for Palestinian Advocacy.

The legal team of Salah Sarsour alleges that he risks death from being denied basic diabetes care after two months in detention.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.